Business / Corporate May 13, 2015
Takeda threatens to end Orexigen partnership over data release
Takeda Pharmaceutical Co. has threatened to end its collaboration with Orexigen Therapeutics Inc. after a safety study of the obesity drug Contrave was halted by researchers who criticized Orexigen for an early release of trial data. "Takeda sent a dispute letter to Orexigen on May ...
